AwardTape · Defense awards · Research and development · Defense systems R&D · 0019
0019: $0 delivery order to Qinetiq Inc
Qinetiq Inc holds a delivery order from Department of the Army with $0 obligated since Oct 2023 and $9.9M obligated over its life, against a ceiling of $10.0M. Latest action Jan 8, 2025.
Igf::ot::igf research, development, engineering, fabrication, modification, integration, and demonstration of systems and associated subsystems capable of providing pilotage, situational awareness, and threat warning information in the ...
| PIID | 0019 |
|---|---|
| Type | delivery order |
| Parent award | W909MY12D0008 |
| Company | Qinetiq Inc |
| Agency | Department of the Army |
| Contracting office | W6QK ACC-APG CONT CT WASH OFC |
| Category | Research and development · Defense systems R&D |
| PSC | AD93 R&D- DEFENSE OTHER: OTHER (ADVANCED DEVELOPMENT) |
| NAICS | 541712 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $9.9M |
| Ceiling (base and all options) | $10.0M |
| Base date | Sep 29, 2015 |
| Latest action | Jan 8, 2025 |
| End date | Sep 28, 2018 |
| Actions since Oct 2023 | 1 |
| Pricing | Cost plus fixed fee |
| Competition | Competed after exclusion of sources |
| Place of performance | VA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial